Sartorius Stedim Biotech SA
PAR:DIM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sartorius Stedim Biotech SA
PAR:DIM
|
FR |
|
Paterson Resources Ltd
ASX:PSL
|
AU |
|
Roche Holding AG
SIX:RO
|
CH |
|
K
|
KPF
KOSDAQ:024880
|
KR |
|
S
|
Sherwood Corporation (Thailand) PCL
SET:SWC
|
TH |
|
BASF India Ltd
NSE:BASF
|
IN |
|
M
|
Medibank Private Ltd
F:MPV
|
AU |
|
T
|
Tung Ho Steel Enterprise Corp
TWSE:2006
|
TW |
|
Owens & Minor Inc
NYSE:ACH
|
US |
|
SOL SpA
MIL:SOL
|
IT |
|
Macfarlane Group PLC
LSE:MACF
|
UK |
|
C
|
Cloudastructure Inc
NASDAQ:CSAI
|
US |
|
J
|
Jasmine Technology Solution PCL
SET:JTS
|
TH |
Wall Street
Price Targets
DIM Price Targets Summary
Sartorius Stedim Biotech SA
According to Wall Street analysts, the average 1-year price target for
DIM
is 240.48 EUR
with a low forecast of 212.1 EUR and a high forecast of 275.1 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is DIM's stock price target?
Price Target
240.48
EUR
According to Wall Street analysts, the average 1-year price target for
DIM
is 240.48 EUR
with a low forecast of 212.1 EUR and a high forecast of 275.1 EUR.
What is Sartorius Stedim Biotech SA's Revenue forecast?
Projected CAGR
10%
For the last 14 years the
compound annual growth rate for
Sartorius Stedim Biotech SA's revenue is
14%.
The projected
CAGR
for the next 3 years is
10%.
What is Sartorius Stedim Biotech SA's Operating Income forecast?
Projected CAGR
23%
For the last 14 years the
compound annual growth rate for
Sartorius Stedim Biotech SA's operating income is
15%.
The projected
CAGR
for the next 3 years is
23%.
What is Sartorius Stedim Biotech SA's Net Income forecast?
Projected CAGR
40%
For the last 14 years the
compound annual growth rate for
Sartorius Stedim Biotech SA's net income is
14%.
The projected
CAGR
for the next 3 years is
40%.
